1/ People are increasingly fed up with COVID, so measures to control Omicron cannot/should not rely on measures used for prior waves. (Which means that governments would be wise not to allow COVID to reach a crisis situation.)
When I highlighted several days ago that case growth was worrying me, several Twitterati assumed that I was alluding to lockdowns. (I was doing nothing of the sort)
But failure to pay attention to cases in EUR shows that countries can be forced into lockdowns if they don't act.
2/ Engineering/environmental controls (e.g. ventilation, filtration) will be the smallest imposition on people's lives.
Better masking (understanding, adherence, quality) would make a difference.
This is without assuming any properties of Omicron.
3/ Full vaccination (i.e. 2 doses until 5-6 months, and then a 3rd) will help with Delta, and probably help with Omicron but how much remains unknown.
This requires govt. and media commentators to unequivocally state that vaccination requires a 3rd dose after 5-6 months.
As highlighted in a thread today, Israel relied on 3rd doses to keep their society open during a Delta wave.
4/ There is a dangerous narrative being circulated that case counts don't matter because of vaccination. It is being amplified by speculation that Omicron will be ok because it causes milder disease.
Vaccination allows us to "tolerate" higher cases but there is likely a ceiling.
5/ If, say, 0.14% of infected people overall died of Delta (IFR) now, then for 5000 cases daily, 7 will die.
Further, widespread circulating virus (Force of Infection) will 📈 likelihood of "finding" the under/unvaccinated, which will thus 📈the effective IFR and📉 VE.
CFR (case fatality rate) isn't exactly the same as IFR, but they are related. Tough to know if CFR has recently gone up in some EUR countries because of waning immunity, FOI, Delta, or decr low-risk testing. But the very recent incr is real. Nordic countries give our best look.
The relationship of VE to FoI was nicely shown by David Kaslow (nature.com/articles/s4154…) with a variety of different real-life non-COVID vax scenarios.
So if we want to optimize VE, it is not only 3rd doses, but keeping case counts under decent (whatever that is) control.
A hint of this comes from comparing 🇰🇷 & 🇯🇵. Their vaccine rollout was comparable, with comparable stringency. Neither should have been susceptible to waning immunity effects yet.
🇯🇵 summer wave was likely due to insufficient vaccination. 🇰🇷 likely Delta + less stringency -> FOI.
6/ This is all difficult to communicate to a fatigued public and—if Omicron is indeed substantially more transmissible—governments will need to carefully communicate the risk.
At present, at least in Ontario, there seems little interest from the government to talk COVID at all.
My bottom line:
- we need to avoid instituting any measures that meaningfully reduce personal freedoms
- cases continue to matter
- maximize vaccinations incl. 3rd dose
- governments should remind people that, sadly, COVID isn't over
- there is +++ uncertainty with Omicron
/Fin
• • •
Missing some Tweet in this thread? You can try to
force a refresh
So much talk about introducing 3rd doses in Canada. This hits close to home because ... I live in Canada!
But I have lived in LMIC, have a parent from a LMIC, and believe that vaccine equity is incredibly important.
Nevertheless, widespread 3rd doses are getting pushback. 🧵
1. Do vaccines work and vaccine efficacy wane?
Hell ya! We have tons of data demonstrating this. Here is just one figure from @FT that shows waning immunity (and then booster effect).
Yes, mRNA is better than AZ, but both wane from their peak efficacy d/t decr neutralizing Abs.
Really important study looking at daily sampling of early SARS-CoV-2 infection in 60 individuals, focusing on viral shedding for up to 14d. medrxiv.org/content/10.110…
Lots of stuff to learn here:
1. Sore throat, runny nose, and muscle aches had strongest relationship with positive viral culture. 2. For most individuals, nasal VL > saliva VL and viral shedding peaks at least 1d earlier in saliva vs. nasal. 3. Viral load is not perfectly predictive of infectiousness.
*4. Massive (i.e. 40-fold) heterogeneity in individual level infectiousness, with imperfect correlation with age. This means that features of the "the spreader" can be a very important contributor to superspreading. 5. No clear explanation of increased transmissibility of VOCs.
The 2021 AMR Preparedness Index is an excellent effort to look at what is 1 of our most pressing public health issues as some countries emerge from the COVID-19 pandemic: #AntimicrobialResistance
There are important findings for Canadians and their leaders: 1. We ain't so good!
2. We are behind the UK, US, France, Germany, India and Japan on a national strategy.
"Governments must make bolder financial investments ...
... should develop more ambitious National Action Plans and provide sufficient funding to achieve goals ... lean into AMR initiatives now"
3. We are kinda pathetic on governments' commitments to foster and support AMR innovation.
Govts "should implement pull incentive programs within the next 3 years ...
increase investments in AMR innovations for surveillance and diagnostics ...
ensure pricing reflects full value"
To my colleagues & trainees who have contacted me in distress over the past few days, I see you and hear you.
I don't post my thoughts about the Middle East because—even though I have studied its history tremendously over the years—I recognize that there are more than one truth.
I understand how you fear—as Jews or people sympathetic to the tragedy that Israelis are experiencing—expressing your views or trying to counter views that see only one side of a dispute that is much older than the state of Israel.
I also understand how uncomfortable you have been made to feel when colleagues or supervisors use their (mostly) professional platform to acknowledge the unquestionable and tragic suffering of Palestinians yet fail to acknowledge the suffering many Israelis are also experiencing.
Reluctantly, I feel I need to clarify some issues around why AZ doesn't make sense for most of Canada right now.
When NACI evaluated—using the hard endpoint of deaths—the risk-benefit of AZ vs. no AZ, it used a lower incidence 1 per 100 000.
With this modeling, it makes clear sense to give AZ vs. waiting for age 50-69 in a moderate incidence setting, and for all ages in high incidence setting.
But what happens if the VITT rate is 1:26 000 or 3.85/100 000? You get this ...
This means that it is only a slam dunk (vs. no vaccine) for age 50+ in high incidence (30 cases/100K/day) settings, and 40+ in very high incidence (60 cases/100K/day) settings. Even if VITT incidence is 1:40 000 (or 2.5/100K/day), your expected VITT deaths/100K are 0.63-1.0.
It all hinges on the estimates of VITT. Yesterday @COVIDSciOntario posted a VITT brief covid19-sciencetable.ca/sciencebrief/v… that gave updated estimates of risk: 1:26 000 to 1:127 000 (as opposed to govt doc using 1:100-250K), and I believe ours is the most accurate estimate of risk of VITT.
If we use the revised numbers, the incidence of an ICU admission from AZ vaccine becomes anywhere from 1.27-3.85/100 000. Using existing risk-benefit analysis, it means that it never makes "statistical sense" to use an AZ vaccine where the COVID incidence is moderate (7.5/100K/d)